Efficacy of acupuncture for cardiopulmonary cerebral resuscitation: A systematic review and meta-analysis

Liu Yunlan,Ren Mengjuan,Kuang Zhuoran,Luo Xufei,Li Huishan,Zhang Yikai,Wen Wanxin,Cai Yefeng,Ni Xiaojia,Chen Yaolong 한국한의학연구원 2023 Integrative Medicine Research Vol.12 No.1

Background: Cerebral resuscitation is one of the main therapeutic aims in the treatment of cardiac arrest (CA) patients who experience a return of spontaneous circulation (ROSC). However, the therapeutic effects of current treatments are not ideal. The purpose of this study was to evaluate the efficacy of neurological function of acupuncture combined with conventional cardiopulmonary cerebral resuscitationthe (CPCR) for patients after ROSC. Methods: Seven electronic databases and other related websites were searched to identify studies on acupuncture combined with conventional CPCR for patients after ROSC. R software was used to conduct a meta-analysis, and the outcomes that could not be pooled were analyzed using a descriptive analysis. Results: Seven RCTs involving 411 participants who had experienced ROSC were eligible for inclusion. The main acupoints were Neiguan (PC6), Shuigou (DU26), Baihui (DU20), Yongquan (KI1), and Sanyinjiao (SP6). Compared to conventional CPCR, acupuncture combined with conventional CPCR led to signifi- cantly higher Glasgow Coma Scale (GCS) scores on day 3 (mean difference (MD) = 0.89, 95% CI: 0.43, 1.35, I 2 = 0%), day 5 (MD = 1.21, 95% CI: 0.27, 2.15; I 2 = 0%), and day 7 (MD = 1.92, 95% CI: 1.35, 2.50; I 2 = 0%). Conclusion: Acupuncture-assisted conventional CPCR may have a potential role in improving neurologi- cal function in CA patients after ROSC, but the certainty of evidence is very low and more high-quality studies are required.

The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A scoping review

Mengjuan Ren,Yunlan Liu,Xiaojia Ni,Zhuoran Kuang,Xufei Luo,Yikai Zhang,Huishan Li,Yaolong Chen 한국한의학연구원 2022 Integrative Medicine Research Vol.11 No.4

Introduction This study aims to summarize the available evidence and guideline/consensus recommendations for acupuncture and moxibustion in the treatment, prevention and rehabilitation of patients with coronavirus disease 2019 (COVID-19). Methods A scoping review was performed. Eight electronic databases and other related websites were searched. All studies related to acupuncture and moxibustion for COVID-19 were considered. Descriptive analysis was applied to analyze the all included studies and guideline recommendations. Results We ultimately included 131 eligible studies. The main topics of the included studies were the treatment (82.4%) and prevention (38.9%) of COVID-19. The most included studies were literature reviews (65, 49.6%), protocols of systematic reviews (20, 15.3%), and guidelines and consensuses (18, 13.7%). The 18 (13.7%) COVID-19 guidelines and consensuses included 47 recommendations on acupuncture and moxibustion, which focused on the treatment (21/47, 44.7%), rehabilitation (17/47, 36.2%) and prevention (6, 12.8%) of COVID-19 patients. Zusanli (ST36), Feishu (BL13), Guanyuan (RN4) were recommended mostly for the treatment, rehabilitation and prevention respectively. Conclusion Acupuncture and moxibustion are effective in the treatment of COVID-19 patients to some extent. However, more high-quality of clinical trials still needed to determine the feasibility of acupuncture and moxibustion in COVID-19 patients to better guide clinical practice. Study registration Open Science Framework Registries (Registration DOI: 10.17605/OSF.IO/Z35WN; https://osf.io/z35wn). Introduction This study aims to summarize the available evidence and guideline/consensus recommendations for acupuncture and moxibustion in the treatment, prevention and rehabilitation of patients with coronavirus disease 2019 (COVID-19). Methods A scoping review was performed. Eight electronic databases and other related websites were searched. All studies related to acupuncture and moxibustion for COVID-19 were considered. Descriptive analysis was applied to analyze the all included studies and guideline recommendations. Results We ultimately included 131 eligible studies. The main topics of the included studies were the treatment (82.4%) and prevention (38.9%) of COVID-19. The most included studies were literature reviews (65, 49.6%), protocols of systematic reviews (20, 15.3%), and guidelines and consensuses (18, 13.7%). The 18 (13.7%) COVID-19 guidelines and consensuses included 47 recommendations on acupuncture and moxibustion, which focused on the treatment (21/47, 44.7%), rehabilitation (17/47, 36.2%) and prevention (6, 12.8%) of COVID-19 patients. Zusanli (ST36), Feishu (BL13), Guanyuan (RN4) were recommended mostly for the treatment, rehabilitation and prevention respectively. Conclusion Acupuncture and moxibustion are effective in the treatment of COVID-19 patients to some extent. However, more high-quality of clinical trials still needed to determine the feasibility of acupuncture and moxibustion in COVID-19 patients to better guide clinical practice. Study registration Open Science Framework Registries (Registration DOI: 10.17605/OSF.IO/Z35WN; https://osf.io/z35wn).

Comparative mitochondrial genomics and phylogenetics among species of the Oriental dobsonfly genus Neoneuromus van der Weele, 1909 (Megaloptera: Corydalidae)

Tu Yuezheng,Lin Aili,Jiang Yunlan,Liu Xingyue 한국응용곤충학회 2021 Journal of Asia-Pacific Entomology Vol.24 No.4

The dobsonfly genus Neoneuromus van der Weele, 1909 represents one of the megalopteran lineages with large body-size, and comprises 13 species all endemic to the Oriental region. In the present study, the mitochondrial genomes (mitogenomes) of 12 species of this genus were determined and analyzed for the first time. The mitogenome of the genus-type, Neoneuromus fenestralis (McLachlan, 1869), as a representative of these conge neric species, is herein described in detail. All of the mitogenomes of Neoneuromus are composed of 37 encoded genes and a control region. The evolutionary rates of the protein coding genes (PCGs) of the 13 species of Neoneuromus as well as different genera of Corydalinae are estimated. All the transfer RNA genes (tRNAs) have the typical clover-leaf secondary structure except trnS1 (AGN). Interspecific relationships within Neoneuromus were reconstructed based on different datasets generated from mitogenomic sequences. Our results indicate that tRNA and ribosomal RNA genes (rRNAs) of Neoneuromus species contribute phylogenetic signal when being concatenated with the PCGs, thus should be kept during phylogenetic analysis. The results sheds light on un derstanding the evolution of these aquatic and predatory insects.

Decreased expression of ATF3, orchestrated by β-catenin/TCF3, miR-17-5p and HOXA11-AS, promoted gastric cancer progression via increased β-catenin and CEMIP

Xie Guohua,Dong ping,Chen Hui,Xu Ling,Liu Yi,Ma Yanhui,Zheng Yingxia,Yang Junyao,Zhou Yunlan,Chen Lei,Shen Lisong 생화학분자생물학회 2021 Experimental and molecular medicine Vol.53 No.-

ATF3 has been reported to be dysregulated in various cancers and involved in various steps of tumorigenesis. However, the mechanisms underlying the abnormal expression of ATF3 and its biological function in gastric cancer (GC) have not been well investigated. Here, we report ATF3 as one of the key regulators of GC development and progression. Patients with low ATF3 expression had shorter survival and a poorer prognosis. In vitro and in vivo assays investigating ATF3 alterations revealed a complex integrated phenotype that affects cell growth and migration. Strikingly, high-throughput sequencing and microarray analysis of cells with ATF3 silencing or of ATF3-low GC tissues indicated alterations in the Wnt signaling pathway, focal adhesions and adherens junctions. Mechanistically, the expression of β-catenin and cell migration inducing hyaluronidase 1 (CEMIP) was significantly upregulated in GC cells with downregulated ATF3, which was synergistically repressed by the β-catenin/TCF3 signaling axis and noncoding RNA miR-17-5p and HOXA11-AS. In addition, we found that WDR5 expression was promoted by TCF3 and is involved in miR-17-5p and HOXA11-AS activation in GC cells. Taken together, our findings revealed the mechanism of ATF3 downregulation and its biological role in regulating the expression of Wnt signaling-related genes during GC progression, suggesting new informative biomarkers of malignancy and therapeutic directions for GC patients.